Skip to main content
International Journal of Clinical and Experimental Medicine logoLink to International Journal of Clinical and Experimental Medicine
. 2015 Aug 15;8(8):13289–13295.

A comprehensive expression profile of micrornas in rat’s pituitary

Bao Yuan 1,*, Dong-Xu Han 1,*, Li-Sheng Dai 1, Yan Gao 1, Yu Ding 1, Xian-Feng Yu 1, Jian Chen 1, Hao Jiang 1, Cheng-Zhen Chen 1, Jia-Bao Zhang 1
PMCID: PMC4612940  PMID: 26550255

Abstract

MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules that act as a negative regulator of most mRNAs. miRNAs influence the gene expression as transcriptional regulators and play an important role in many fundamental biological processes. It is generally acknowledged that miRNAs have a very important affection on mammalian pituitary. However, the answers of which role miRNAs play in the development of sexual function or how much they contribute to the pituitary function are not exactly. In our study, we used three female 21-day-old rats and three female 12-month-old rats to analysis the function of miRNAs. By the analyses of microarray data, we finished the stem-loop real-time RT-PCR for the differentially expressed miRNAs. We detected a total of 93 differentially expressed miRNAs between 21-day-old rats’ pituitary and 12-month-old rats’. Stem-loop real-time RT-PCR suggests that the obtained data is of high credibility. Among these miRNAs, 7 miRNAs’ expression (rno-miR-880, rno-miR-503, rno-miR-125a-3p, rno-miR-3596b, rno-miR-30e, rno-miR-214 and rno-miR-22) are significant different (P≤0.05). In a word, this study identified a number of specific changes in the expression of miRNAs, in rats by detecting the expression profile of miRNAs in rat’s pituitary, and all of that lay the foundation for elucidating the regulatory mechanisms of miRNAs in rat’s reproduction process. These differentially expressed miRNAs may play a very important role in rat’s reproduction process.

Keywords: MiRNAs, rat pituitary, reproduction

Introduction

MiRNAs are non-protein-coding small RNAs, 19-23 nucleotides in length, which are implicated in the posttranscriptional fine tuning of gene regulation [1]. By base pairing with the 3’ untranslated region (3’ UTR) of their target mRNA, miRNAs results in repression of the target genes expression or degradation of target genes [2-4]. Since the original discovery in nematodes [5], studies have revealed that miRNAs have key roles in diverse processes such as developmental control, hematopoietic cell differentiation, neural development, apoptosis, cell proliferation and organ development [6]. Recent studies indicated that miRNAs play a direct role in apoptosis of bovine corpus luteum [7], which means miRNAs are involved in the reproductive process.

Since the publication of the Rat Genome Sequence [8], rat is more and more important in scientific research. In the year of 2007, some researchers found rats had possessed metacognition and psychological ability previously only documented in humans and some primates [9,10]. From then on, there are many studies about rat’s brain and intelligence, but only a little about its pituitary.

The pituitary, as the most complex internal secretion gland of the mammal, releases seven kinds of hormones to play a part in the whole life course. Thus profiling pituitary miRNAs may enable us to elucidate not only how miRNAs are involved in regulating the development and function of the organ but also how miRNAs are involved in regulating the development of the individual or species characteristics of an animal [11]. However, there only are a few experiments stepped into the regular pattern of pituitary gland.

Drawing the support from microarray, target Combo and DAVID gene annotation tool, we studied the discipline of miRNAs in rat’s pituitary.

Methods

Tissue collection and RNA extraction

Euthanasia was performed by decapitation following anesthetic injection (chloraldurate, 10%), and pituitary glands from three female 21-day-old rats and three female 12-month-old rats (Wistar) were rapidly dissected, and store in liquid nitrogen. Total RNA was isolated by TRIzol according to the explanatory memorandum of manufacturer. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Labo-ratory Animals of the National Institutes of Health. The animal use protocol has been reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Jilin University.

Ethics statement

We strictly abided the provisions of laboratory animal center of Jilin University. All animal procedures were conducted following the protocol (2011-036) approved by the Animal Care & Welfare Committee of Jilin University.

The detection of microarray assay

The miRCURY™ Hy3™/Hy5™ Power labeling kit (Exiqon, Vedbaek, Denmark) was used according to the manufacturer’s guideline for miRNA labelling. One microgram of each sample was 3’-end-labeled with Hy3TM fluorescent label by using T4 RNA ligase provided in the kit as described following. The RNA mixture (3 μL) with 1.0 μL of CIP Buffer (Exiqon) was incubated for 30min at 37°C, terminated by 95°C for 5 min. Then 3.0 μL labeling buffer, 1.5 μL fluorescent label (Hy3TM), 2.0 μL DMSO and 2.0 μL labeling enzyme were added into the mixture. The labeling reaction was incubated for 1 h at 16°C, and terminated by 65°C for 15 min.

The Hy3TM-labeled samples were hybridized on the miRCURYTM LNA Array (v.16.0) (Exiqon) according to array manual after the termination of the labeling step. All the mixture from Hy3TM-labeled samples mixed with 25 μL hybridization buffer were denatured at 95°C for 2 min, incubated on ice for 2 min and then hybridized to the microarray for 16-20 h at 56°C in a 12-Bay Hybridization Systems (Hybridization System-Nimblegen Systems, Inc., Madison, WI, USA), which provides an active mixing action and constant incubation temperature to improve hybridization uniformity and enhance signal. Following hybridization, the slides were achieved, washed several times with Wash buffer kit (Exiqon), and finally dried by centrifugation for 5 min at 400 rpm. Then the slides were scanned by using the Axon GenePix 4000 B microarray scanner (Axon Instruments, Foster City, CA).

Scanned images were then imported into GenePix Pro 6.0 software (Axon) for grid alignment and data extraction. Replicates were averaged and miRNAs that intensities ≥50 in all samples were chosen for calculating normalization factor. Expressed data were normalized using the median normalization. After normalization, differentially expressed miRNAs were identified through Volcano Plot filtering. Hierarchical clustering was performed using MEV software (v4.6, TIGR).

Stem-loop real-time RT-PCR

Total RNA was extracted as the description above. The primers used for Real-time PCR were provided by Jiusheng Corp (Shanghai, China). Our Stem-loop real-time RT-PCR steps followed the previously described [12].

Complementary DNA was reverse transcribed from 1 µg of total RNA mixing with with 1 μg miRNA-specific RT-primers (Jiusheng Corp, Shanghai, China) by incubating 50 min at 42°C and deactivating 15 min at 75°C. Power SYBR green PCR mix was used for the amplification mixture with each primer 1.5 µl and 1 µl cDNA for a total reaction volume [13] of 20 µl. PCR reactions were performed on STRATAGENE Mx3005P sequence detection system as previously described. Briefly, samples underwent amplification by denaturation at 95 C for 1 min, and then cycled 40 times using 95 C for 15 sec, 56 C for 15 sec and 72 C for 40 sec. All reactions were run in triplicate [14]. Last, we recorded the cycle threshold (Ct) for analysis with U6 RNA.

Results

The regular expressions of miRNAs in rat’s pituitary detected by microarray assay

We entrusted the microarray analysis with Kangchen Bio-tech. The 6th generation of miRNA array contains more than 1891 capture probes, covering all human, mouse and rat microRNAs annotated in miRBase 16.0, as well as all viral microRNAs related to these species. In addition, this array contains capture probes for 66 new miRPlus™ human microRNAs. These are proprietary microRNAs not found in miRBase. By the analysis of microarray data, we detected a total of 93 differentially expressed miRNAs between 21-day-old rats and 12-month-old rats (Tables 1 and 2). Among these miRNAs, 7 miRNAs’ with a fold change >1.5 and a p-test value <0.01 are significant different (Tables 3 and 4). These 7 miRNAs should be the main regulators between the 21-day-old rats and the 12-month-old rats. Then we used Volcano Plot and Heat Map and Hierarchical Clustering for further testing. The results are as follows (Figures 1, 2).

Table 1.

Group 1 vs Group 2 1.5 fold up regulated miRNAs

Name Fold change P-value ForeGround-BackGround

Group 1 vs Group 2 Group 1 vs Group 2 Mean of Group 2 Mean of Group 1
Rno-miR-349 2.4485 0.2028 323.1667 809.5000
Rno-miR-218b 1.9746 0.2333 336.8333 1053.5000
Rno-miR-409-3p 1.7240 0.4844 41.8333 125.5000
Rno-miR-672* 4.5245 0.3571 -3.1667 126.1667
Rno-miR-743b 1.6896 0.1930 32.1667 53.3333
Rno-miR-183 1.6504 0.1842 484.0000 493.1667
Rno-miR-431 1.6594 0.4630 2517.1667 4631.3333
Rno-miR-3597-5p 2.1797 0.1497 121.3333 267.0000
Rno-miR-2964 5.7149 0.2536 -52.6667 72.1667
Rno-miR-494* 21.6344 0.3779 -27.5000 121.6667
Rno-miR-3592 2.0292 0.1096 544.5000 1086.8333
Rno-miR-3591 3.2684 0.4549 14.3333 254.6667
Rno-miR-880 2.6260 0.0067 215.6667 572.8333
Rno-miR-351 1.8834 0.1813 198.3333 366.5000
Rno-miR-449c-3p 2.4601 0.3121 409.6667 1109.0000
Rno-miR-874 1.9655 0.3151 53.1667 110.3333
Rno-miR-211 1.5107 0.3192 146.3333 231.5000
Rno-miR-466b-2* 1.7161 0.5069 117.0000 199.1667
Rno-miR-340-3p 1.9902 0.3923 1914.8333 4210.6667
Rno-miR-199a-3p 1.5757 0.4259 123.3333 188.8333
Rno-miR-500 1.9307 0.4332 -6.8333 30.3333
Rno-miR-221 1.6870 0.3220 175.1667 286.0000
Rno-miR-3563-5p 1.7707 0.5996 -7.8333 35.1667
Rno-miR-433 1.6346 0.0770 659.6667 1069.1667
Rno-miR-107 1.5089 0.2541 304.1667 455.0000
Rno-miR-138 1.5057 0.2273 234.0000 345.0000
Rno-miR-377* 1.6294 0.5047 84.6667 154.5000
Rno-miR-192 1.5644 0.4018 88.3333 221.0000
Rno-miR-511* 2.7856 0.2952 -11.1667 148.5000
Rno-miR-3597-3p 1.6560 0.3463 734.6667 1180.0000
Rno-miR-204 1.7792 0.3125 133.3333 245.0000
Rno-miR-186 1.7421 0.1911 130.6667 227.0000
Rno-miR-219-2-3p 1.8049 0.2362 250.0000 435.1667
Rno-miR-503 2.6714 0.0160 70.8333 385.5000
Rno-miR-770* 1.8442 0.1563 211.3333 381.0000
Rno-miR-3581 1.5845 0.3631 -23.0000 36.5000
Rno-miR-136* 2.4591 0.1559 1075.5000 2686.3333
Rno-miR-675* 1.6565 0.5534 110.1667 376.5000
Rno-miR-125a-3p 2.2408 0.0131 153.0000 346.1667
Rno-miR-505* 2.5868 0.1550 141.0000 357.1667
Rno-miR-206 2.0189 0.2072 103.5000 328.5000
Rno-miR-331* 1.6290 0.7458 16.5000 74.0000
Rno-miR-18a* 1.5098 0.5932 -16.1667 40.0000
Rno-miR-3596a 1.9819 0.2679 491.3333 979.8333
Rno-miR-3544 1.9393 0.3228 276.1667 712.3333
Rno-miR-30c-1* 2.3394 0.6563 -14.8333 107.0000
Rno-miR-199a-5p 1.5305 0.5148 46.1667 115.6667
Rno-miR-34b* 1.9660 0.0945 5347.3333 11030.1667
Rno-miR-330* 1.7412 0.1497 206.3333 350.1667
Rno-miR-133b 1.5794 0.2379 207.3333 348.0000
Rno-miR-122* 2.4618 0.4716 35.3333 379.1667
Rno-miR-466d 5.3503 0.2543 3.5000 125.1667
Rno-miR-100 1.7910 0.2371 131.3333 245.3333
Rno-miR-382* 1.6467 0.3734 196.0000 308.6667
Rno-miR-154 1.6600 0.0859 254.8333 443.5000
Rno-miR-3596b 2.3654 0.0479 4769.8333 11446.3333

Table 2.

Group 1 vs Group 2 1.5 fold down regulated miRNAs

Name Fold change P-value ForeGround-BackGround

Group 1 vs Group 2 Group 1 vs Group 2 Mean of Group 2 Mean of Group 1
Rno-miR-200b 0.3483 0.1571 177.5000 69.1667
Rno-miR-30e 0.4015 0.0291 350.1667 142.6667
Rno-miR-665 0.4601 0.6049 24.3333 8.1667
Rno-miR-330 0.2593 0.4208 506.6667 134.6667
Rno-miR-466c* 0.5133 0.5372 1263.6667 634.0000
Rno-miR-29a 0.3096 0.1740 3679.0000 1167.8333
Rno-miR-425 0.4685 0.4351 660.5000 291.8333
Rno-miR-125b-5p 0.5454 0.2492 2974.1667 1652.3333
Rno-miR-540 0.5276 0.2840 25.3333 25.6667
Rno-miR-434 0.4180 0.3902 2510.6667 1071.3333
Rno-miR-352 0.3318 0.3136 335.8333 110.1667
Rno-miR-181a 0.3047 0.4014 1490.0000 457.3333
Rno-miR-30a 0.2803 0.3533 2771.3333 793.1667
Rno-miR-214* 0.1826 0.0257 7.6667 3.8333
Rno-miR-101a 0.2092 0.1388 1368.8333 285.8333
Rno-miR-23a 0.4345 0.1547 202.0000 84.5000
Rno-miR-34c 0.5321 0.3468 542.5000 287.1667
Rno-miR-341 0.4803 0.3416 971.3333 492.0000
Rno-miR-3583-5p 0.6639 0.3414 843.8333 591.6667
Rno-miR-335 0.0466 0.1690 1906.6667 46.5000
Rno-miR-135a 0.1962 0.2150 293.1667 25.3333
Rno-miR-329* 0.6218 0.5528 191.1667 117.3333
Rno-miR-144 0.5820 0.4766 306.3333 173.3333
Rno-miR-200c 0.3558 0.1318 1732.3333 614.5000
Rno-miR-551b* 0.2037 0.1200 1108.1667 219.0000
Rno-miR-296 0.5130 0.4816 80.1667 81.6667
Rno-miR-22 0.4079 0.1896 4353.6667 1814.3333
Rno-miR-127* 0.4520 0.0511 161.6667 71.3333
Rno-miR-375 0.3724 0.0913 938.1667 348.1667
Rno-miR-7a 0.5096 0.2571 14681.1667 7672.8333
Rno-miR-16 0.3363 0.1206 697.0000 232.8333
Rno-miR-141 0.2726 0.2616 2722.6667 455.6667
Rno-miR-22* 0.4228 0.0253 46.8333 43.6667
Rno-miR-339-5p 0.6450 0.5270 314.5000 212.5000
Rno-miR-30b-5p 0.5224 0.1993 777.8333 426.3333
Rno-miR-374 0.3231 0.1900 355.5000 123.0000
Rno-miR-324-5p 0.5221 0.1374 313.1667 163.1667
Rno-miR-551b 0.0159 0.1570 227.1667 -4.3333

Table 3.

Group 1 vs Group 2 1.5 fold up regulated miRNAs

Name Fold change P-value ForeGround-BackGround

Group 1 vs Group 2 Group 1 vs Group 2 Mean of Group 2 Mean of Group 1
Rno-miR-880 2.6260 0.0067 215.6667 572.8333
Rno-miR-503 2.6714 0.0160 70.8333 385.5000
Rno-miR-125a-3p 2.2408 0.0131 153.0000 346.1667
Rno-miR-3596b 2.3654 0.0479 4769.8333 11446.3333

Table 4.

Group 1 vs Group 2 1.5 fold down regulated miRNAs

Name Fold change P-value ForeGround-BackGround

Group 1 vs Group 2 Group 1 vs Group 2 Mean of Group 2 Mean of Group 1
Rno-miR-30e 0.4015 0.0291 350.1667 142.6667
Rno-miR-214* 0.1826 0.0257 7.6667 3.8333
Rno-miR-22* 0.4228 0.0253 46.8333 43.6667

Figure 1.

Figure 1

The vertical lines correspond to 1.5-fold up and down, respectively, and the horizontal line represents a P-value of 0.05. So the red point in the plot represents the differentially expressed genes with statistically significance. The red refer to the significant differently expressed miRNAs.

Figure 2.

Figure 2

Each row represents a miRNA and each column represents a sample. The miRNA clustering tree is shown on the left, and the sample clustering tree appears at the top. The color scale shown at the top illustrates the relative expression level of a miRNA in the certain slide: red color represents a high relative expression level; green color represents a low relative expression levels.

Real-time RT- PCR for miRNA microarray validation

In order to confirm the correctness and the reliability of the microarray data, we finished the Stem-loop real-time RT-PCR for the 7 miRNAs. The result of real-time RT-PCR suggested that our microarray data are reliable (Figure 3).

Figure 3.

Figure 3

To verify and evaluate the reliability of the results from the microarray data, we selected 7 differentially expressed miRNAs for stem-loop real-time PCR assay. All the miRNAs were successfully detected by the real-time PCR, suggesting that the miRNAs identified by our microarray analysis were reliable for their existence. The expression levels determined by real-time PCR assay were quite consistent with those determined by microarray analysis.

Discussion

MiRNAs are small, approximately 22 nucleotide (nt), single-stranded non-coding RNA molecules. MiRNAs were first discovered in the nematode Caenorhabditis elegans in 1993 by Lee et al. [5] MiRNAs have been identified in a wide range of species, including bacteria, plants, animals, and even viruses [15,16]. MiRNAs have been shown to play an important role in regulating many fundamental biological processes, including cell proliferation, differentiation, apoptosis, cell adhesion, metabolism, cell migration, neurogenesis, stress resistance, and hemopoiesis [17].

Under normal circumstances, the mature miRNAs are involved in maintaining normal cell homeostasis by regulating the translation or stability of target gene mRNAs. Therefore, the abnormal expression of miRNAs may lead to the abnormal expression at the level of the corresponding target gene transcript [18]. Currently, the main mechanism of miRNAs is that miRNAs complementarily combine with the 3’UTR of the target gene by RNA-induced Gene Silencing Complexes (RISCs) [19]. MiRNAs perform the function that estimate regulate 10-30% of all protein coding genes in two ways [20]. The first mode is operative in plants, where in miRNAs bind to perfectly complementary base pairs on the target mRNA, thus inducing its cleavage [21,22]. The alternative and more common method involves the imperfect binding of miRNAs to partially complementary sites on the 3’ UTR of target mRNA leading to some degree of mRNA degradation and inhibition of protein translation [23].

In recent years, some scholars using target scan method predicted 400 miRNAs target genes, which are related to the mammalian development of 13 percent. And a plurality of experiments has shown that miRNAs play an important role in mammalian development. However, the studies of which role miRNAs play in the development of sexual function or how much they contribute to the pituitary function are not sufficient. This study detected the expressions of relevant miRNAs in rat’s pituitary by gene-chip. By the analysis of microarray data, it detected a total of 93 differentially expressed miRNAs between 21-day-old rats and 12-month-old rats, including 56 up regulated miRNAs and 38 down regulated miRNAs. These 7 miRNAs should be the main regulators between the 21-day-old rats and the 12-month-old rats. These miRNAs may play an important regulating role in the function of rat’s pituitary. And then this study utilized Target Combo to predicting the 7 miRNAs’ target genes. It is possible to work through these genes in the development of rat sexual function, and the mechanism will be elucidated by further experiments. In a word, this study identified a number of specific changes in the expression of miRNAs in rats by detecting the expression profile of miRNAs in Rat’s Pituitary. It was also preliminarily validated by PT-PCR, and all of that lay the foundation for elucidating the regulatory mechanisms of miRNAs in rat’s reproduction process.

Acknowledgements

National Key Technology R&D Program (2011BAD19B04), The National High-tech Research and Development Program (2013AA102505). National Natural Science Foundation of China (31030058, 31501954).

Disclosure of conflict of interest

None.

References

  • 1.Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell. 2009;36:61–74. doi: 10.1016/j.molcel.2009.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, Liang Z. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. World J Gastroenterol. 2011;17:3353–3358. doi: 10.3748/wjg.v17.i28.3353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.German MA, Luo S, Schroth G, Meyers BC, Green PJ. Construction of Parallel Analysis of RNA Ends (PARE) libraries for the study of cleaved miRNA targets and the RNA degradome. Nat Protoc. 2009;4:356–362. doi: 10.1038/nprot.2009.8. [DOI] [PubMed] [Google Scholar]
  • 4.Schmiedel JM, Axmann IM, Legewie S. Multi-target regulation by small RNAs synchronizes gene expression thresholds and may enhance ultrasensitive behavior. PLoS One. 2012;7:e42296. doi: 10.1371/journal.pone.0042296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854. doi: 10.1016/0092-8674(93)90529-y. [DOI] [PubMed] [Google Scholar]
  • 6.Saugstad JA. MicroRNAs as effectors of brain function. Stroke. 2013;44:S17–19. doi: 10.1161/STROKEAHA.113.000985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Arainga M, Takeda E, Aida Y. Identification of bovine leukemia virus tax function associated with host cell transcription, signaling, stress response and immune response pathway by microarray-based gene expression analysis. BMC Genomics. 2012;13:121. doi: 10.1186/1471-2164-13-121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill R, Celera , Holt RA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Fosler C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahill P, Kana A, Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra M, Schein J, Bosdet I, Fjell C, Jones S, Krzywinski M, Mathewson C, Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y, Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Worley KC, Cooney AJ, D’Souza LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang Z, Bailey JA, Eichler EE, Tuzun E, Birney E, Mongin E, Ureta-Vidal A, Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D, Alexandersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels S, Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar Albà M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O, Poliakov A, Hübner N, Ganten D, Goesele C, Hummel O, Kreitler T, Lee YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H, Jacob HJ, Bromberg S, Gullings-Handley J, Jensen-Seaman MI, Kwitek AE, Lazar J, Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM, Rice S, Goodstadt L, Beatson SA, Emes RD, Winter EE, Webber C, Brandt P, Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara P, Hardison RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko A, Riemer C, Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K, Andrews TD, Caccamo M, Clamp M, Clarke L, Curwen V, Durbin R, Eyras E, Searle SM, Cooper GM, Batzoglou S, Brudno M, Sidow A, Stone EA, Venter JC, Payseur BA, Bourque G, López-Otín C, Puente XS, Chakrabarti K, Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A, Tesler G, Pevzner PA, Haussler D, Roskin KM, Baertsch R, Clawson H, Furey TS, Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR, Trumbower H, Weirauch M, Cooper DN, Stenson PD, Ma B, Brent M, Arumugam M, Shteynberg D, Copley RR, Taylor MS, Riethman H, Mudunuri U, Peterson J, Guyer M, Felsenfeld A, Old S, Mockrin S, Collins F Rat Genome Sequencing Project Consortium. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature. 2004;428:493–521. doi: 10.1038/nature02426. [DOI] [PubMed] [Google Scholar]
  • 9.Arai M, Genda Y, Ishikawa M, Shunsuke T, Okabe T, Sakamoto A. The miRNA and mRNA changes in rat hippocampi after chronic constriction injury. Pain Med. 2013;14:720–729. doi: 10.1111/pme.12066. [DOI] [PubMed] [Google Scholar]
  • 10.Hou Y, Sun Y, Shan H, Li X, Zhang M, Zhou X, Xing S, Sun H, Chu W, Qiao G, Lu Y. β-adrenoceptor regulates miRNA expression in rat heart. Med Sci Monit. 2012;18:BR309–314. doi: 10.12659/MSM.883263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Li H, Xi Q, Xiong Y, Cheng X, Qi Q, Yang L, Shu G, Wang S, Wang L, Gao P, Zhu X, Jiang Q, Zhang Y, Yuan L. A comprehensive expression profile of microRNAs in porcine pituitary. PLoS One. 2011;6:e24883. doi: 10.1371/journal.pone.0024883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yu CY, Yin BC, Ye BC. A universal real-time PCR assay for rapid quantification of microRNAs via the enhancement of base-stacking hybridization. Chem Commun (Camb) 2013;49:8247–8249. doi: 10.1039/c3cc44125c. [DOI] [PubMed] [Google Scholar]
  • 13.Feng J, Wang K, Liu X, Chen S, Chen J. The quantification of tomato microRNAs response to viral infection by stem-loop real-time RT-PCR. Gene. 2009;437:14–21. doi: 10.1016/j.gene.2009.01.017. [DOI] [PubMed] [Google Scholar]
  • 14.Wan G, Lim QE, Too HP. High-performance quantification of mature microRNAs by real-time RT-PCR using deoxyuridine-incorporated oligonucleotides and hemi-nested primers. RNA. 2010;16:1436–1445. doi: 10.1261/rna.2001610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.O’Connor RM, Grenham S, Dinan TG, Cryan JF. microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int J Neuropsychopharmacol. 2013;16:1885–1892. doi: 10.1017/S1461145713000448. [DOI] [PubMed] [Google Scholar]
  • 16.Zhu H, Luo H, Zuo X. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma. Exp Mol Med. 2013;45:e41. doi: 10.1038/emm.2013.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14:535–548. doi: 10.1038/nrg3471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bras-Rosario L, Matsuda A, Pinheiro AI, Gardner R, Lopes T, Amaral A, Gama-Carvalho M. Expression profile of microRNAs regulating proliferation and differentiation in mouse adult cardiac stem cells. PLoS One. 2013;8:e63041. doi: 10.1371/journal.pone.0063041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tang F, Hajkova P, O’Carroll D, Lee C, Tarakhovsky A, Lao K, Surani MA. MicroRNAs are tightly associated with RNA-induced gene silencing complexes in vivo. Biochem Biophys Res Commun. 2008;372:24–29. doi: 10.1016/j.bbrc.2008.04.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bose I, Ghosh S. Origins of binary gene expression in post-transcriptional regulation by microRNAs. Eur Phys J E Soft Matter. 2012;35:102. doi: 10.1140/epje/i2012-12102-2. [DOI] [PubMed] [Google Scholar]
  • 21.Ryazansky SS, Gvozdev VA, Berezikov E. Evidence for post-transcriptional regulation of clustered microRNAs in Drosophila. BMC Genomics. 2011;12:371. doi: 10.1186/1471-2164-12-371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tsunetsugu-Yokota Y, Yamamoto T. Mammalian MicroRNAs: Post-Transcriptional Gene Regulation in RNA Virus Infection and Therapeutic Applications. Front Microbiol. 2010;1:108. doi: 10.3389/fmicb.2010.00108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Williams AE. Functional aspects of animal microRNAs. Cell Mol Life Sci. 2008;65:545–562. doi: 10.1007/s00018-007-7355-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Medicine are provided here courtesy of e-Century Publishing Corporation

RESOURCES